Such a series of studies would be costly, so a critical challenge is funding. These costs deserve to be placed in context of the public health implications of these disorders and, historically, psychiatric research has ben underfunded in comparison to public health impact (with the possible exception of AD). 141–144 For example, the lifetime cost per person with SCZ is on the order of $US 1.4 million: 145 if this program of research were eventually able to prevent only several dozen cases, it would likely prove to be cost-effective.
